Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-022750

President and Head of R&D sold 57,054 shares at $2.85 ($162,604)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nagendran Sukumar President and Head of R&D 2025-08-21 Sale −57,054 $2.85 $162,604 1,165,289 D
Open-market sales · 57,054 sh · avg $2.85 · $162,604
Loading xslF345X05/form4-08222025_040806.xml…